Literature DB >> 12673838

The role of rib infarcts in the acute chest syndrome of sickle cell diseases.

D L Rucknagel1.   

Abstract

The acute chest syndrome is a generic term for pulmonary complications of sickle cell diseases with heterogeneous etiologies that include pneumonia, vaso-occlusion of pulmonary arterioles, rib infarction, and fat embolism syndrome. My review summarizes these etiologies, the evidence, and pathophysiology supporting the hypothesis that infarction of segments of ribs by the same vaso-occlusive process responsible for the acute episodes of pain (characteristic of the sickle cell diseases) is often involved in the acute chest structure. Inflammation associated with the infarct then causes splinting, hypoventilation, and hypoxia and further vaso-occlusion. The relationship with adult respiratory distress syndrome and fat embolism is also discussed. Use of the incentive spirometer combined with effective analgesia when chest pain is present is advocated for prevention of the pulmonary infiltrates. Newer understanding of the role of nitric oxide in regulating oxygen transport and its relationship to blood transfusions used in therapy of the acute chest syndrome are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12673838

Source DB:  PubMed          Journal:  Pediatr Pathol Mol Med        ISSN: 1522-7952


  6 in total

Review 1.  Sickle cell diseases: current therapeutic options and potential pitfalls in preventive therapy for transcranial Doppler abnormalities.

Authors:  Sharada A Sarnaik
Journal:  Pediatr Radiol       Date:  2005-02-10

Review 2.  Pathophysiology of Sickle Cell Disease.

Authors:  Prithu Sundd; Mark T Gladwin; Enrico M Novelli
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

3.  Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE).

Authors:  Lori Styles; Carrie G Wager; Richard J Labotka; Kim Smith-Whitley; Alexis A Thompson; Peter A Lane; Lillian E C McMahon; Robin Miller; Susan D Roseff; Rathi V Iyer; Lewis L Hsu; Oswaldo L Castro; Kenneth I Ataga; Onyinye Onyekwere; Maureen Okam; Rita Bellevue; Scott T Miller
Journal:  Br J Haematol       Date:  2012-03-30       Impact factor: 6.998

4.  Respiratory muscle force and lung volume changes in a population of children with sickle cell disease.

Authors:  Bruce A Ong; Jason Caboot; Abbas Jawad; Joseph McDonough; Tannoa Jackson; Raanan Arens; Carole L Marcus; Kim Smith-Whitley; Thornton B A Mason; Kwaku Ohene-Frempong; Julian L Allen
Journal:  Br J Haematol       Date:  2013-07-20       Impact factor: 6.998

5.  The Acute Chest Syndrome in Cameroonian children living with sickle cell disease.

Authors:  Jobert Richie N Nansseu; Anastasie Nicole Alima Yanda; David Chelo; Sandra A Tatah; Hubert D Mbassi Awa; Judith Seungue; Paul Olivier N Koki
Journal:  BMC Pediatr       Date:  2015-09-21       Impact factor: 2.125

Review 6.  Acute Chest Syndrome in Children with Sickle Cell Disease.

Authors:  Shilpa Jain; Nitya Bakshi; Lakshmanan Krishnamurti
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2017-12-01       Impact factor: 1.349

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.